What were Epigral Ltd's latest quarterly results?
Epigral Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -6.9%
- Revenue Growth YoY: +17.2%
- Operating Margin: 23.0%
Epigral Ltd: Stock Analysis & Fundamentals
Updated this weekEpigral Ltd (Pesticides/Agrochemicals) — fundamental analysis, earnings data, and key metrics. PE: 14.8. ROE: 16.0%. This stock is not currently in the Nifty 500 momentum outperformers list.
Epigral Ltd Key Facts
What's Happening
👔Promoter stake down 2.8% this quarter
🌐FII stake increased 0.6% this quarter
🏛️DII accumulation — stake up 3.8%
Key Numbers
Current Price
₹1,130
Dividend Yield
0.44%
Market Cap
4.9K Cr
Valuation
N/AOther Top Pesticides/Agrochemicals Stocks Beating Nifty 500
Frequently Asked Questions: Epigral Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Epigral Ltd's current PE ratio?
Epigral Ltd's current PE ratio is 14.8x.
- Current PE: 14.8x
- Market Cap: 4.9K Cr
- Dividend Yield: 0.44%
What is Epigral Ltd's price-to-book ratio?
Epigral Ltd's price-to-book ratio is 2.2x.
- Price-to-Book (P/B): 2.2x
- Book Value per Share: ₹515
- Current Price: ₹1130
Is Epigral Ltd a fundamentally strong company?
Epigral Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 15.0%
Is Epigral Ltd debt free?
Epigral Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹572 Cr
What is Epigral Ltd's return on equity (ROE) and ROCE?
Epigral Ltd's return ratios over recent years
- FY2024: ROCE 17.0%
- FY2025: ROCE 25.0%
- FY2026: ROCE 15.0%
Is Epigral Ltd's cash flow positive?
Epigral Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹436 Cr
- Free Cash Flow (FCF): ₹81 Cr
- CFO/PAT Ratio: 131% (strong cash conversion)
What is Epigral Ltd's dividend yield?
Epigral Ltd's current dividend yield is 0.44%.
- Dividend Yield: 0.44%
- Current Price: ₹1130
Who holds Epigral Ltd shares — promoters, FII, DII?
Epigral Ltd's shareholding pattern (Mar 2026)
- Promoters: 68.8%
- FII (Foreign): 1.5%
- DII (Domestic): 4.9%
- Public: 24.7%
Is promoter holding increasing or decreasing in Epigral Ltd?
Epigral Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 68.8% (Mar 2026)
- Previous Quarter: 68.8% (Dec 2025)
- Change: 0.00% (stable)
Is Epigral Ltd a new momentum entry or an established outperformer?
Epigral Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Epigral Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Epigral Ltd may be worth studying
- Cash flow is positive — CFO ₹436 Cr
What is the investment thesis for Epigral Ltd?
Epigral Ltd investment thesis summary:
What is the future outlook for Epigral Ltd?
Epigral Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.